Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLRX2 mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | increases expression | ISO | Glrx2 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of GLRX2 mRNA | CTD | PMID:28960355 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of GLRX2 mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Glrx2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GLRX2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLRX2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GLRX2 mRNA | CTD | PMID:23152189 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of GLRX2 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GLRX2 mRNA | CTD | PMID:30851411 | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | Glrx2 (Mus musculus) | 6480464 | [3 more ... | CTD | PMID:24378064 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Glrx2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GLRX2 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GLRX2 mRNA | CTD | PMID:36041667 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of GLRX2 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of GLRX2 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GLRX2 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of GLRX2 mRNA | CTD | PMID:30047161 | aristolochic acid A | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of GLRX2 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GLRX2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | GLRX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GLRX2 exon and Benzo(a)pyrene results in increased methylation of GLRX2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GLRX2 mRNA | CTD | PMID:31255691 | bisphenol A | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of GLRX2 mRNA | CTD | PMID:19371625 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GLRX2 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | Glrx2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GLRX2 mRNA | CTD | PMID:33221593 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GLRX2 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GLRX2 mRNA | CTD | PMID:36041667 | cannabidiol | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of GLRX2 mRNA | CTD | PMID:27714895 | carbamazepine | affects expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GLRX2 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlordecone | decreases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of GLRX2 mRNA | CTD | PMID:29980752 | cisplatin | affects response to substance | ISO | GLRX2 (Homo sapiens) | 6480464 | GLRX2 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | cisplatin | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of GLRX2 mRNA | CTD | PMID:27392435 | clotrimazole | increases expression | EXP | | 6480464 | Clotrimazole results in increased expression of GLRX2 mRNA | CTD | PMID:30047161 | copper atom | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA | CTD | PMID:24690739 | copper(0) | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA | CTD | PMID:24690739 | crocidolite asbestos | decreases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of GLRX2 mRNA | CTD | PMID:29279043 | Diallyl sulfide | increases expression | EXP | | 6480464 | allyl sulfide results in increased expression of GLRX2 mRNA | CTD | PMID:19768707 | dibenzo[a,l]pyrene | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | dibenzo(a and l)pyrene results in decreased expression of GLRX2 mRNA | CTD | PMID:31255691 | disulfiram | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA | CTD | PMID:24690739 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of GLRX2 mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | elemental selenium | affects activity | EXP | | 6480464 | Selenium affects the activity of GLRX2 protein | CTD | PMID:19351701 | elemental selenium | affects expression | EXP | | 6480464 | Selenium affects the expression of GLRX2 protein | CTD | PMID:19351701 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of GLRX2 mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of GLRX2 mRNA | CTD | PMID:24136188 | genistein | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Genistein results in increased expression of GLRX2 mRNA | CTD | PMID:19371625 | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of GLRX2 promoter | CTD | PMID:23740543 | isotretinoin | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of GLRX2 mRNA | CTD | PMID:20436886 | mercury dibromide | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of GLRX2 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA | CTD | PMID:27188386 | Mesaconitine | decreases expression | EXP | | 6480464 | mesaconitine results in decreased expression of GLRX2 protein | CTD | PMID:37182599 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of GLRX2 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GLRX2 mRNA | CTD | PMID:23649840 | methylene blue | multiple interactions | ISO | Glrx2 (Mus musculus) | 6480464 | [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of GLRX2 mRNA | CTD | PMID:24556215 | methylmercury chloride | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GLRX2 mRNA | CTD | PMID:28001369 and PMID:29581082 | mono(2-ethylhexyl) phthalate | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of GLRX2 mRNA | CTD | PMID:23360888 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of GLRX2 mRNA | CTD | PMID:24136188 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of GLRX2 mRNA | CTD | PMID:24136188 | ozone | multiple interactions | ISO | Glrx2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GLRX2 mRNA | CTD | PMID:27106289 | panobinostat | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | panobinostat results in increased expression of GLRX2 mRNA | CTD | PMID:26272509 | paraquat | decreases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of GLRX2 mRNA | CTD | PMID:12732627 | paraquat | increases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Paraquat results in increased expression of GLRX2 mRNA | CTD | PMID:21371552 | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of GLRX2 mRNA | CTD | PMID:19768707 | phenylmercury acetate | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of GLRX2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA | CTD | PMID:27188386 | phlorizin | decreases expression | ISO | Glrx2 (Mus musculus) | 6480464 | Phlorhizin results in decreased expression of GLRX2 mRNA | CTD | PMID:22538082 | pirinixic acid | multiple interactions | ISO | Glrx2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GLRX2 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | Glrx2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GLRX2 mRNA | CTD | PMID:20813756 | potassium chromate | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLRX2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of GLRX2 mRNA | CTD | PMID:22079256 | quercetin | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of GLRX2 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GLRX2 mRNA | CTD | PMID:30851411 | resveratrol | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | resveratrol results in increased expression of GLRX2 mRNA | CTD | PMID:19371625 | SB 431542 | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | affects activity | EXP | | 6480464 | Selenium affects the activity of GLRX2 protein | CTD | PMID:19351701 | selenium atom | affects expression | EXP | | 6480464 | Selenium affects the expression of GLRX2 protein | CTD | PMID:19351701 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of GLRX2 mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of GLRX2 mRNA | CTD | PMID:31533062 | toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of GLRX2 mRNA | CTD | PMID:21827849 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of GLRX2 gene | CTD | PMID:27618143 | trichostatin A | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GLRX2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GLRX2 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | GLRX2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GLRX2 mRNA | CTD | PMID:23179753 more ... | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of GLRX2 mRNA | CTD | PMID:19015723 | zearalenone | increases expression | ISO | GLRX2 (Homo sapiens) | 6480464 | Zearalenone results in increased expression of GLRX2 mRNA | CTD | PMID:19371625 | |